Head And Neck Cancer

The addition of stereotactic body radiation therapy to nivolumab did not improve outcomes among a cohort of patients with metastatic head and neck squamous cell carcinoma, according to a study published in Journal of Clinical Oncology.

The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma, study results showed.

The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma, study results showed.

RNA sequencing detected less than half of identifiable genetic mutations found in DNA sequencing of thyroid and brain tumor, thyroid tissue and fine-needle aspiration samples, according to findings published in Thyroid.

The FDA approved the FoundationOne CDx test to help identify certain neurotrophic receptor tyrosine kinase gene fusions in patients with solid tumors eligible for treatment with larotrectinib, according to a press release from the agency.

Increased rates of certain infections, such as influenza, gastroenteritis, hepatitis and pneumonia, appeared associated with an eventual cancer diagnosis, according to research published in Cancer Immunology Research.

Models projecting incidence of low-risk papillary thyroid cancers suggest there will be more than 200,000 new thyroid cancer diagnoses during the next 5 years, with at least 67,000 of those cases qualifying as candidates for active surveillance due to small tumor size, according to findings published in JAMA Otolaryngology Head & Neck Surgery.

For many patients with head and neck cancer, treatment-associated oral mucositis is a source of severe pain.

European Society for Medical Oncology will present Lillian L. Siu, MD, FRCPC, with the TAT 2020 Honorary Award.

Researchers found that adults exposed to radiation from CT scans had an increased risk for thyroid cancer and leukemia. It was one of the top stories in hematology/oncology last week.